PHK
IDYA icon

Point72 Hong Kong’s IDEAYA Biosciences IDYA Stock Holding History

Point72 Hong Kong’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,376
Closed -$38K – 2143
2022
Q1 		$38K Buy
3,376
+2,648
+364% +$39K ﹤0.01% 1411
2021
Q4 		$17K Buy
+728
New +$16.9K ﹤0.01% 1569
2021
Q2 		– Sell
-538
Closed -$13K – 2109
2021
Q1 		$13K Buy
538
+254
+89% +$4.9K ﹤0.01% 1555
2020
Q4 		$4K Buy
+284
New +$3.85K ﹤0.01% 1607
2020
Q3 		– Sell
-162
Closed -$2K – 1339
2020
Q2 		$2K Sell
162
-33
-17% -$260 ﹤0.01% 1071
2020
Q1 		$1K Hold
195
– – ﹤0.01% 876
2019
Q4 		$1K Hold
195
– – ﹤0.01% 1103
2019
Q3 		$2K Sell
195
-1,048
-84% -$8K ﹤0.01% 868
2019
Q2 		$12K Buy
+1,243
New +$13.5K ﹤0.01% 843

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 Hong Kong's IDYA Position: Q2 2022 in Review

Point72 Hong Kong sold out of IDEAYA Biosciences (IDYA) in Q2 2022, closing a stake of 3,376 shares — an estimated $38K sold.

Point72 Hong Kong first reported a position in IDYA in Q2 2019 and held it in 9 quarters. The position peaked at $38K in Q1 2022. 96 funds tracked by Wall St. Rank hold IDYA as of Q2 2022.

  • Point72 Hong Kong reported no remaining IDEAYA Biosciences position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,376 IDEAYA Biosciences shares in Q2 2022, an estimated $38K.
  • Point72 Hong Kong first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 9 quarters.
  • Point72 Hong Kong's IDEAYA Biosciences position peaked at $38K in Q1 2022.
  • 96 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.